Evaluation of Neuroma Perfusion With Indocyanine Green Fluorescence Angiography

• Status: Enrolling by invitation
• Trial end date: 2024-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to characterize the perfusion of neuromas using indocyanine green fluorescence angiography

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Northwestern University
• Collaborator: American Society for Surgery of the Hand

Criteria

Inclusion Criteria:

• Age > 18 years

• Clinical diagnosis of neuroma

• Scheduled elective surgery for neuroma excision

Exclusion Criteria:

• Minors, or age < 18 years old at the time of surgery

• Unable to provide written, informed consent

• Prisoners and decision-impaired individuals

• Pregnant or lactating women

• History of allergy to indocyanine green

• History of allergy to iodides

• History of allergic asthma

• History of hepatic failure

• History of renal failure

• Patients in whom the planned surgical incision/approach does not include excision of the neuroma

• Patients in whom adequate surgical exposure of the neuroma is unable to be obtained, as determined intraoperatively at the time of surgery by the Investigator or Co-Investigators

• Any subject who, at the discretion of the Investigator or Co-Investigators, is not suitable for inclusion in the study